Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other brea... Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use. Show more
SEATTLE, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), today announced its support of the U.S. Food and Drug Administration (FDA) for...
SEATTLE, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (βAtossaβ or the βCompanyβ), today announced its participation in theΒ H.C. Wainwright 26th Annual Global...
SEATTLE, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (βAtossaβ or the βCompanyβ), today announced that the United States Patent and Trademark Office (USPTO) has...
SEATTLE, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (βAtossaβ or the βCompanyβ) and Quantum Leap Healthcare Collaborativeβ’ (QLHC), today announced the first...
SEATTLE, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) today announced the appointment of Michael Parks as Vice President of Investor and Public Relations. Mr. Parks...
Presented data showing 100% disease control rate after 24-week treatment with (Z)-Endoxifen in 40mg cohort of Phase 2 EVANGELINE study at the American Association for Cancer Research (AACR) Annual...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0901 | -5.88888888889 | 1.53 | 1.53 | 1.38 | 698390 | 1.44633425 | CS |
4 | 0.0099 | 0.692307692308 | 1.43 | 1.55 | 1.29 | 595272 | 1.42529806 | CS |
12 | 0.2499 | 21 | 1.19 | 1.55 | 1.09 | 689974 | 1.34454652 | CS |
26 | -0.2101 | -12.7333333333 | 1.65 | 2.31 | 1.02 | 1216969 | 1.53986197 | CS |
52 | 0.6348 | 78.8473481555 | 0.8051 | 2.31 | 0.62 | 901579 | 1.38826363 | CS |
156 | -1.9901 | -58.0204081633 | 3.43 | 3.5299 | 0.5 | 1179942 | 1.54469866 | CS |
260 | -0.6701 | -31.7582938389 | 2.11 | 9.8 | 0.5 | 3526622 | 3.17320662 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.